Analyst Color News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cross-linked news, and information resources about biological weapons

Those who cared to invest in one of the most obscure financial assets at the beginning of 2017 laughed their way to the bank at the end of the year.  Most digital currencies made heady gains for the year, with bitcoin advancing 1,308 percent. XRP, the Ripple token currency, was up an even... Read More...

UiPath Inc (NYSE: PATH) shares are up more than 20% since the company priced its April IPO at $56. UiPath automates repetitive workplace processes. The company reported $607.6 million in revenue in the last fiscal year, up 81% year-over-year. At the same time, UiPath’s net loss narrowed from... Read More...

U.S. stocks rose as investors and traders digested comments from the Federal Reserve. The Federal Reserve Open Committee announced that it will further taper its asset purchases by another $10 billion. The Fed is now committing towards purchasing $35 billion of assets per month. The Fed also... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:

In a report published Friday, Oppenheimer analyst Akiva Felt initiated coverage of Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) with an Outperform rating and a price target of $18. Analyst Akiva Felt believes that Tonix has been "overlooked" by investors after mixed Phase 2... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to: